CN103070338A - Blueberry chewable tablet - Google Patents
Blueberry chewable tablet Download PDFInfo
- Publication number
- CN103070338A CN103070338A CN2013100583725A CN201310058372A CN103070338A CN 103070338 A CN103070338 A CN 103070338A CN 2013100583725 A CN2013100583725 A CN 2013100583725A CN 201310058372 A CN201310058372 A CN 201310058372A CN 103070338 A CN103070338 A CN 103070338A
- Authority
- CN
- China
- Prior art keywords
- blueberry
- chewable tablets
- chewable tablet
- mixing
- maltodextrin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 235000003095 Vaccinium corymbosum Nutrition 0.000 title claims abstract description 48
- 235000017537 Vaccinium myrtillus Nutrition 0.000 title claims abstract description 48
- 235000021014 blueberries Nutrition 0.000 title claims abstract description 48
- 239000007910 chewable tablet Substances 0.000 title claims abstract description 25
- 229940068682 chewable tablet Drugs 0.000 title abstract 4
- 244000077233 Vaccinium uliginosum Species 0.000 title description 19
- 240000000851 Vaccinium corymbosum Species 0.000 claims abstract description 29
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims abstract description 18
- 239000000843 powder Substances 0.000 claims abstract description 18
- 238000002156 mixing Methods 0.000 claims abstract description 12
- 238000001035 drying Methods 0.000 claims abstract description 10
- 239000005913 Maltodextrin Substances 0.000 claims abstract description 9
- 229920002774 Maltodextrin Polymers 0.000 claims abstract description 9
- 235000013325 dietary fiber Nutrition 0.000 claims abstract description 9
- 229940035034 maltodextrin Drugs 0.000 claims abstract description 9
- 229940055416 blueberry extract Drugs 0.000 claims description 13
- 235000019216 blueberry extract Nutrition 0.000 claims description 13
- 239000002994 raw material Substances 0.000 claims description 10
- 239000000463 material Substances 0.000 claims description 9
- 238000002360 preparation method Methods 0.000 claims description 9
- 239000003826 tablet Substances 0.000 claims description 9
- 235000021552 granulated sugar Nutrition 0.000 claims description 8
- 238000005303 weighing Methods 0.000 claims description 8
- 239000008187 granular material Substances 0.000 claims description 7
- 235000020985 whole grains Nutrition 0.000 claims description 7
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 claims description 5
- 238000004519 manufacturing process Methods 0.000 abstract description 5
- 238000010298 pulverizing process Methods 0.000 abstract description 3
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 abstract 2
- 235000021551 crystal sugar Nutrition 0.000 abstract 1
- 238000000605 extraction Methods 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 abstract 1
- 235000019359 magnesium stearate Nutrition 0.000 abstract 1
- 238000003825 pressing Methods 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 15
- 210000001508 eye Anatomy 0.000 description 15
- 230000004438 eyesight Effects 0.000 description 15
- 230000036541 health Effects 0.000 description 13
- 239000000047 product Substances 0.000 description 13
- 238000000034 method Methods 0.000 description 9
- 230000006870 function Effects 0.000 description 8
- 208000003464 asthenopia Diseases 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 7
- 229930014669 anthocyanidin Natural products 0.000 description 6
- 150000001453 anthocyanidins Chemical class 0.000 description 6
- 235000008758 anthocyanidins Nutrition 0.000 description 6
- 235000013399 edible fruits Nutrition 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 235000016709 nutrition Nutrition 0.000 description 6
- 230000035764 nutrition Effects 0.000 description 5
- 150000003254 radicals Chemical class 0.000 description 5
- 230000001093 anti-cancer Effects 0.000 description 4
- 210000004204 blood vessel Anatomy 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 206010012601 diabetes mellitus Diseases 0.000 description 4
- 230000036039 immunity Effects 0.000 description 4
- 239000002932 luster Substances 0.000 description 4
- 230000002265 prevention Effects 0.000 description 4
- 206010028980 Neoplasm Diseases 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 230000032683 aging Effects 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 230000003078 antioxidant effect Effects 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- 210000001367 artery Anatomy 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 230000004379 myopia Effects 0.000 description 3
- 208000001491 myopia Diseases 0.000 description 3
- 230000004436 pseudomyopia Effects 0.000 description 3
- 239000011701 zinc Substances 0.000 description 3
- 229910052725 zinc Inorganic materials 0.000 description 3
- NCYCYZXNIZJOKI-IOUUIBBYSA-N 11-cis-retinal Chemical compound O=C/C=C(\C)/C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-IOUUIBBYSA-N 0.000 description 2
- 208000024827 Alzheimer disease Diseases 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 102000004330 Rhodopsin Human genes 0.000 description 2
- 108090000820 Rhodopsin Proteins 0.000 description 2
- 208000034189 Sclerosis Diseases 0.000 description 2
- 206010039966 Senile dementia Diseases 0.000 description 2
- 235000009754 Vitis X bourquina Nutrition 0.000 description 2
- 235000012333 Vitis X labruscana Nutrition 0.000 description 2
- 240000006365 Vitis vinifera Species 0.000 description 2
- 235000014787 Vitis vinifera Nutrition 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 230000008485 antagonism Effects 0.000 description 2
- 235000010208 anthocyanin Nutrition 0.000 description 2
- 229930002877 anthocyanin Natural products 0.000 description 2
- 239000004410 anthocyanin Substances 0.000 description 2
- 150000004636 anthocyanins Chemical class 0.000 description 2
- 230000003064 anti-oxidating effect Effects 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 239000000496 cardiotonic agent Substances 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 229910052802 copper Inorganic materials 0.000 description 2
- 239000010949 copper Substances 0.000 description 2
- 210000003792 cranial nerve Anatomy 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 230000003179 granulation Effects 0.000 description 2
- 230000004217 heart function Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 230000015654 memory Effects 0.000 description 2
- 210000000196 olfactory nerve Anatomy 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 230000004304 visual acuity Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 244000099147 Ananas comosus Species 0.000 description 1
- 235000007119 Ananas comosus Nutrition 0.000 description 1
- PYIXHKGTJKCVBJ-UHFFFAOYSA-N Astraciceran Natural products C1OC2=CC(O)=CC=C2CC1C1=CC(OCO2)=C2C=C1OC PYIXHKGTJKCVBJ-UHFFFAOYSA-N 0.000 description 1
- NDVRQFZUJRMKKP-UHFFFAOYSA-N Betavulgarin Natural products O=C1C=2C(OC)=C3OCOC3=CC=2OC=C1C1=CC=CC=C1O NDVRQFZUJRMKKP-UHFFFAOYSA-N 0.000 description 1
- 208000014644 Brain disease Diseases 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 206010007191 Capillary fragility Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010009185 Ciliary muscle spasm Diseases 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010017533 Fungal infection Diseases 0.000 description 1
- 206010018367 Glomerulonephritis chronic Diseases 0.000 description 1
- XINCECQTMHSORG-UHFFFAOYSA-N Isoamyl isovalerate Chemical compound CC(C)CCOC(=O)CC(C)C XINCECQTMHSORG-UHFFFAOYSA-N 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- 240000008790 Musa x paradisiaca Species 0.000 description 1
- 235000018290 Musa x paradisiaca Nutrition 0.000 description 1
- 208000031888 Mycoses Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- IHPVFYLOGNNZLA-UHFFFAOYSA-N Phytoalexin Natural products COC1=CC=CC=C1C1OC(C=C2C(OCO2)=C2OC)=C2C(=O)C1 IHPVFYLOGNNZLA-UHFFFAOYSA-N 0.000 description 1
- 206010060862 Prostate cancer Diseases 0.000 description 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 208000002495 Uterine Neoplasms Diseases 0.000 description 1
- 206010047571 Visual impairment Diseases 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000021028 berry Nutrition 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 230000008499 blood brain barrier function Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000001772 blood platelet Anatomy 0.000 description 1
- 210000001218 blood-brain barrier Anatomy 0.000 description 1
- 210000004958 brain cell Anatomy 0.000 description 1
- 210000005252 bulbus oculi Anatomy 0.000 description 1
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 1
- 235000013539 calcium stearate Nutrition 0.000 description 1
- 239000008116 calcium stearate Substances 0.000 description 1
- 210000001736 capillary Anatomy 0.000 description 1
- 230000003130 cardiopathic effect Effects 0.000 description 1
- 239000012677 causal agent Substances 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000003930 cognitive ability Effects 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 239000013068 control sample Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 230000003412 degenerative effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 239000007938 effervescent tablet Substances 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 208000030533 eye disease Diseases 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 210000005067 joint tissue Anatomy 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000007937 lozenge Substances 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 239000002366 mineral element Substances 0.000 description 1
- 230000004297 night vision Effects 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 235000019629 palatability Nutrition 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- SBNFWQZLDJGRLK-UHFFFAOYSA-N phenothrin Chemical compound CC1(C)C(C=C(C)C)C1C(=O)OCC1=CC=CC(OC=2C=CC=CC=2)=C1 SBNFWQZLDJGRLK-UHFFFAOYSA-N 0.000 description 1
- 239000000280 phytoalexin Substances 0.000 description 1
- 150000001857 phytoalexin derivatives Chemical class 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000001508 potassium citrate Substances 0.000 description 1
- 229960002635 potassium citrate Drugs 0.000 description 1
- QEEAPRPFLLJWCF-UHFFFAOYSA-K potassium citrate (anhydrous) Chemical compound [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 description 1
- 235000011082 potassium citrates Nutrition 0.000 description 1
- 201000010041 presbyopia Diseases 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 210000001525 retina Anatomy 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 230000006403 short-term memory Effects 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- ANRHNWWPFJCPAZ-UHFFFAOYSA-M thionine Chemical compound [Cl-].C1=CC(N)=CC2=[S+]C3=CC(N)=CC=C3N=C21 ANRHNWWPFJCPAZ-UHFFFAOYSA-M 0.000 description 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
- 208000019206 urinary tract infection Diseases 0.000 description 1
- 206010046766 uterine cancer Diseases 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 208000029257 vision disease Diseases 0.000 description 1
- 230000004393 visual impairment Effects 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
Landscapes
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a blueberry chewable tablet with a healthcare function, and the chewable tablet comprises the following ingredients: blueberry extraction powder, crystal sugar, citric acid, maltodextrin, soluble dietary fibers, flavoring orange essence and magnesium stearate. The blueberry chewable tablet is produced through the production process such as pulverizing, mixing, pelleting, drying and pressing.
Description
Technical field
The present invention relates to a kind of composition with health care, particularly a kind ofly contain the blueberry extract powder and added the compositions such as citric acid, maltodextrin, through the production technologies such as pulverizing, mixing, granulation, oven dry, compacting, the chewable tablets of making.
Background technology
Blueberry (Blueberry), the Latin formal name used at school: Semen Trigonellae means the meaning of blue berry.It is blue that a kind of little berry, fruit are, and color and luster is beautiful, pleasing, blue and wrapped up by 1 layer of white fruit powder, the pulp exquisiteness, and seed is minimum.Sweet and sour palatability, and have fragrant refreshing pleasant fragrance, for eating good merchantable brand raw.
Except sugar, acid and the Vc of routine, be rich in VE, VA, VB, SOD, ursin, protein, anthocyanin, dietary fibre and abundant K, Fe, the mineral elements such as Zn, Ca in the Blueberry.Blueberry belongs to the nutrition and health care fruit of homoamino acid, high zinc, high calcium, high ferro, high-copper, homovitamin.It not only has good nutrition health-care functions, also has the functions such as the cranial nerve of preventing is aging, cardiac stimulant, anticancer softening blood vessel, enhancing human organism immunity.
Blueberry contains abundant nutritional labeling, belongs to the nutrition and health care fruit of homoamino acid, high zinc, high calcium, high ferro, high-copper, homovitamin.It not only has good nutrition health-care functions, also have prevent that cranial nerve is aging, cardiac stimulant, anticancer, softening blood vessel, enhancing people's the functions such as human body immunity, its nutritive value is far above fruit such as apple, grape, oranges, can be rated as " king of world's fruit ". but because the blueberry fancy price, it is far away as welcome as apple, the orange at present.
The effect of blueberry and effect
(1) quick-acting protection eyes, fabulous function of improving eyesight is called as the treasured of eyeshield.Along with the age increases; erythrolabe is decomposed in the eyes; and the VMA in the Blueberry (anthocyani pigment) can protect the capilary of eyes; improve blood circulation; promote erythrolabe synthetic again; can improve vision, widen the vision, alleviate eye fatigue, strengthen night vision, prevention, long-term taking can keep eyesight lasting.
(2) in and free radical, anti-oxidant, strengthen body immunity.Free radical can directly cause 100 various diseases, comprises various cancers, cardiovascular and cerebrovascular, artery sclerosis, diabetes etc.Blueberry anthocyanin content is the abundantest; the special molecular structure of anthocyanidin; can make free radical become stable; can not form the dangerous substance that can cause chain reaction again; also can form the anti-oxidation protection film with collagen; Cell protection and organizing not by free-radical oxidation helps VC, VE to absorb, and strengthens antioxidation.
(3) delay the cranial nerve aging, strengthen memory, the prevention senile dementia.The blueberry compound can promote the growth of memory reflection district brain cell, improve short-term memory, improve cognitive ability, pass through blood-brain barrier, improve the degeneration senile dementia, delay and transform senile symptom, treatment Parkinson's and Alzheimer degenerative brain disorder have rejuvenescent magical effect.
(4) reduce cholesterol, the protection blood vessel strengthens cardiac function.The compound that can resist fungal infection is arranged in the blueberry, can reduce body's cholesterol, prevention of obesity, strengthen VAR, reduce capillary fragility, keep blood vessel penetrating, strengthen the function of capillary, vein, artery, promote the circulatory system, strengthen skin elasticity, improve varication and oedema, suppress blood platelet and solidify, formation and the artery sclerosis of pre-preventing thrombosis reduce the cardiovascular disease incidence rate.
(5) eliminate inflammation in the body, have the effect of anticancer.Flavonoids isoreactivity compound in the blueberry, can kill food-borne causal agent, strengthen useful growth of lactobacillus, especially to urinary tract infections, chronic nephritis, leukaemia, non-bacterial inflammation such as arthritis etc. have the preventive and therapeutic effect that is showing the most, can strengthen the function of joint and soft tissue, Blueberry contains cancer-resisting substance such as selenium etc., and the enzymatic activity that cancer cell is bred rapidly is suppressed.Can prevent and treat liver cancer, the cancer of the uterus, prostate cancer, breast cancer etc.
(6) prevent and treat the other diseases that diabetes and diabetes cause.Phytoalexin in the blueberry " pterostibene " is free from side effects except norcholesterol, can also regulate blood sugar, prevents and treats type II diabetes, can reduce the initiation potential of diabetes, the generation of complication.
The effect blueberry contains cyanine two pigments, has activation retina effect, can strengthen eyesight, prevents that eyeball is tired;
Blueberry is rich in vitamin C, and the enhancing cardiac function is arranged, and pre-anti-cancer and cardiopathic effect can prevent that cranial nerve is old and feeble, it is mental to promote;
The effect target that blueberry is pursued except anthocyanidin intrinsic anti-oxidant, anti-aging, improve the immunity function, more lay particular emphasis on the increase alleviating asthenopia, eliminate the intraocular free radical, promote rhodopsin to generate, the effect of antagonism pseudo-myopia.
Blueberry be a kind of have anti-oxidant, improve ciliary spasm, promote rhodopsin to generate, improve scotopia, eliminate the intraocular free radical, antagonism pseudo-myopia and visual fatigue effect.It is contained to human body beneficial's composition anthocyanidin, takes generation and reparation that this product can resist pseudo-myopia.For reducing the adolescent myopia rate, improve eyesight, improve teen-age eye health and played positive effect.Take this product for adult's eyesight inferior health, as visual fatigue, eye do, eye is puckery, visual impairment etc.; Old people's presbyopia and the prevention of eye disease have good help and improvement effect, for people's eye health care provides more more options, erect firm defence line for people's eye is healthy.
At present, blueberry goods aspect is most of with effervescent tablet, lozenge, liquid beverage form both at home and abroad, adds in addition in other food.Be necessary to provide the new oral form of blueberry to adapt to adolescent myopia crowd's needs.
Summary of the invention
The inventor is through research, develop a kind of, good mouthfeel, color and luster is stable, the blueberry chewable tablets of just melt in the mouth.Blueberry chewable tablets of the present invention, according to percentage by weight, its prescription is composed as follows:
Blueberry extract powder 2%
White granulated sugar 70%
Citric acid 3%
Maltodextrin 7%
Soluble dietary fiber 15%
Flavoring orange essence 2%,
Dolomol 1%
Raw material in the above prescription all can be bought in market and obtain.As: the multiple logical soluble dietary fiber powder of trade name unit, the blueberry extract powder that Shaanxi Si Nuote Bioisystech Co., Ltd and Guangzhou Thailand imperial biochemical technology Co., Ltd produce, blueberry extract powder of the present invention, also can from Blueberry, extract according to prior art and obtain, described blueberry extract powder, preferred anthocyanidin content wherein is 10%-40%, such as the blueberry extract powder of east, Huizhou plant health Science and Technology Ltd. production.
Blueberry chewable tablets of the present invention, its preparation method is as follows:
1. raw material is after crushed got in weighing, accurately takes by weighing various dry powder raw materials by each formula rate;
2, be dry mixed, mixing of materials is even;
3, wet mixing adds water with the material after being dry mixed and carries out wet mixing;
4, granulate;
5, drying is with particle drying;
6, whole grain;
7, compressing tablet.
Described preparation method belongs to the routine techniques for preparing tablet, and only needing according to a conventional method, preparation gets final product.
Blueberry formula of chewable tablets of the present invention obtains through screening, and screening process is as follows:
Sample of the present invention and the control sample in the embodiment of the invention used in experiment, wherein the mouthfeel experiment adopts 10 people to taste the marking mode, full marks are 100 minutes, comprehensive 10 people scoring, color and luster adopts 40 ℃ of degree of temperature, and humidity 70 incubators were placed 30 days, observes color and luster and changes, dissolution velocity adopts sample to place 20 ℃ of water to stir, to all dissolving the required time.
Blueberry chewable tablets of the present invention is take the blueberry powder as raw material, add white granulated sugar, food additives (citric acid, maltodextrin) grape powdered flavor dolomol, the directly edible blueberry chewable tablets of making through certain technique such as pulverizing, mixing, granulation, drying, compacting, metering, packing.
Blueberry chewable tablets of the present invention has the characteristics such as pure natural, nutrition and health care, meets Present Domestic to consume fashion outward, and be the daily first-selected good merchantable brand of selecting of consumer, product has wide market prospects.
In modern society, TV, the extensive of automobile and computer popularized, the increase of operating pressure and life stress, eye fatigue and associated illness in eye get more and more.According to U.S. nutritionist suggestion, eat the blueberry product every day, can reach the purpose of eye health.According to the U.S., Japan, the scholar of European Section research, often edible blueberry goods can strengthen eyesight, anti-eye strain significantly.
Blueberry chewable tablets of the present invention is the science compositing formula, is presented as that ecosystem, content are high, three characteristics of mouthfeel.Its technique is special, makes the formulation that can chew, be conducive to absorb---chewable tablets.Change traditional tablet with the method for making of starch as auxiliary type agent, make this product in taking process, its active ingredient can be absorbed by the body equably, has greatly improved bioavilability, gives full play to the active ingredient effect of product, improves effect.
No matter the science of blueberry chewable tablets of the present invention prescription, or the advance of technique formulation, all unique have leading characteristics.Especially at anthocyanidin to aspect the human eye health care, this project has had new breakthrough and development.This Project Product market utilizes and has a extensive future.
The technique of blueberry chewable tablets of the present invention and formulation have had very much progress, have improved bioavilability, and effect is significantly increased.This product could be introduced to the market rapidly, improves occupation rate of market, also is that compatriots' the crowds such as eye health care, especially adolescent myopia provide a kind of health care to select!
By clinical observation, to alleviating asthenopia, improve the successful of eyesight.
By clinical observation, blueberry chewable tablets tool of the present invention has some improvement, improves eyesight and strengthens the effect that eyes are looked the aspects such as thing endurance
1,8-18 years old, more than eyesight improving 2 row (standard logarithmic visual acuity chart sighting target), the eyesight endurance improved 30%;
2, adult, more than eyesight improving 1 row (standard logarithmic visual acuity chart sighting target), the eyesight endurance improves 20%;
3, the mouthfeel satisfaction reaches 95%;
4, bioavilability improves 32% than like product (such as the blueberry chewable tablets of extra large king's production).
Blueberry chewable tablets of the present invention and similar products at home and abroad compare, and following many index all is higher than prior art:
1, improve eyesight, strengthen and to look the thing endurance;
2, bioavilability;
3, mouthfeel satisfaction;
4, anthocyanidin content.
The research and development success of this project is also put on market as compatriots' eye healthyly, and especially teen-age eye health provides the material support.
The product description of blueberry chewable tablets of the present invention is as follows:
[name of product] common name: the bright board blueberry of a thousand li chewable tablets [Main Ingredients and Appearance] blueberry extract
[specification] 1g/ grain [shelf-life] [storage procedures] shading in 18 months, sealing are preserved at shady and cool dry place.[points for attention] this product can not replace medicine.[manufacturing enterprise] enterprise name: the bright medicine company of Liaoning a thousand li Group Co.,Ltd
The specific embodiment:
Further specify by the following examples the present invention, but not as limitation of the present invention.
Embodiment 1, the prescription 1 that experiment is adopted
Blueberry extract powder 2g
White granulated sugar 70g
Citric acid 3g
Maltodextrin 7g
Soluble dietary fiber 15g
Flavoring orange essence 2g
Dolomol 1g
The preparation method is as follows:
Get raw material after crushed, accurately take by weighing by formula rate, mixing of materials is even; Add water-wet; Granulate; Drying, whole grain, compressing tablet.
Below for testing the blueberry formula of chewable tablets that compares usefulness:
The prescription 2 that experiment is adopted
Blueberry extract powder 2g
White granulated sugar 70g
Maltodextrin 7g
Soluble dietary fiber 15g
Flavoring apple essence 2g
Calcium stearate 1g
The preparation method is as follows:
Get raw material after crushed, accurately take by weighing by formula rate, mixing of materials is even; Add water-wet; Granulate; Drying, whole grain, compressing tablet.
The prescription 3 that experiment is adopted
Blueberry extract powder 2g
White granulated sugar 70g
Tartaric acid 3g
Soluble dietary fiber 15g
Flavoring pineapple essence 2g
Talcum powder 1g
The preparation method is as follows:
Get raw material after crushed, accurately take by weighing by formula rate, mixing of materials is even; Add water-wet; Granulate; Drying, whole grain, compressing tablet.
The prescription 4 that experiment is adopted
Blueberry extract powder 2g
White granulated sugar 70g
Lactic acid 3g
Maltodextrin 7g
Flavoring banana essence 2g
Superfine silica gel powder 1g
The preparation method is as follows:
Get raw material after crushed, accurately take by weighing by formula rate, mixing of materials is even; Add water-wet; Granulate; Drying, whole grain, compressing tablet.
The prescription 5 that experiment is adopted
Blueberry extract powder 2g
White granulated sugar 70g
Potassium citrate 3g
Maltodextrin 7g
Soluble dietary fiber 15g
Dolomol 1g
The preparation method is as follows:
Get raw material after crushed, accurately take by weighing by formula rate, mixing of materials is even; Add water-wet; Granulate; Drying, whole grain, compressing tablet.
Claims (2)
1. blueberry chewable tablets, its prescription is composed as follows:
Blueberry extract powder 2%
White granulated sugar 70%
Citric acid 3%
Maltodextrin 7%
Soluble dietary fiber 15%
Flavoring orange essence 2%,
Dolomol 1%.
2. the preparation method of the described blueberry chewable tablets of claim 1 is characterized in that, step is as follows: get raw material after crushed, accurately take by weighing by formula rate, mixing of materials is even; Add water-wet; Granulate; Drying, whole grain, compressing tablet.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2013100583725A CN103070338B (en) | 2013-02-25 | 2013-02-25 | Blueberry chewable tablet |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2013100583725A CN103070338B (en) | 2013-02-25 | 2013-02-25 | Blueberry chewable tablet |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103070338A true CN103070338A (en) | 2013-05-01 |
| CN103070338B CN103070338B (en) | 2013-11-27 |
Family
ID=48147200
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2013100583725A Active CN103070338B (en) | 2013-02-25 | 2013-02-25 | Blueberry chewable tablet |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103070338B (en) |
Cited By (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103494134A (en) * | 2013-08-28 | 2014-01-08 | 沈阳农业大学 | Blueberry lozenge for relieving asthenopia and preparation method thereof |
| CN104366328A (en) * | 2014-11-07 | 2015-02-25 | 柳城县天地自然食品有限公司 | Chewable tablets containing blueberries and poria cocos, and preparation method of chewable tablets |
| CN104522645A (en) * | 2014-12-09 | 2015-04-22 | 大兴安岭至臻尚品寒带生物技术有限公司 | Formula of blueberry anthocyanin tablets and production process of blueberry anthocyanin tablets |
| CN104621552A (en) * | 2013-11-12 | 2015-05-20 | 江苏艾兰得营养品有限公司 | Eyesight protecting and improving chewable tablet and preparation method thereof |
| CN104814995A (en) * | 2015-05-12 | 2015-08-05 | 沈小玲 | Oriental blueberry fruit powder health product composition as well as preparation method and application thereof |
| CN105533316A (en) * | 2014-11-04 | 2016-05-04 | 威海特伦斯生物工程有限公司 | Production method of blueberry chewable tablets for alleviating visual fatigue |
| CN106036626A (en) * | 2016-06-16 | 2016-10-26 | 湖北工业大学 | Mulberry wine lees chewable tablet preparation method |
| CN106343548A (en) * | 2016-08-24 | 2017-01-25 | 东北林业大学 | Composite licoflavone blueberry juice chewable tablet and preparation method thereof |
| CN110522030A (en) * | 2019-10-12 | 2019-12-03 | 烟台华康海洋食品有限公司 | A kind of sea cucumber nutrient chewable tablets and preparation method thereof |
| CN110710673A (en) * | 2019-09-26 | 2020-01-21 | 南宁海王健康生物科技有限公司 | Blueberry compound vitamin C chewable tablet and preparation method thereof |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1759745A (en) * | 2005-10-11 | 2006-04-19 | 辽宁红树莓产业发展有限公司 | Hygienical functional food of blue berry and preparation method |
| CN101385769A (en) * | 2008-10-24 | 2009-03-18 | 上海应用技术学院 | Blueberry pearl chewing tablet and preparation method thereof |
-
2013
- 2013-02-25 CN CN2013100583725A patent/CN103070338B/en active Active
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1759745A (en) * | 2005-10-11 | 2006-04-19 | 辽宁红树莓产业发展有限公司 | Hygienical functional food of blue berry and preparation method |
| CN101385769A (en) * | 2008-10-24 | 2009-03-18 | 上海应用技术学院 | Blueberry pearl chewing tablet and preparation method thereof |
Non-Patent Citations (1)
| Title |
|---|
| 左曙辉等: "膳食补充片剂(胶囊)的生产", 《中国食品添加剂》 * |
Cited By (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103494134A (en) * | 2013-08-28 | 2014-01-08 | 沈阳农业大学 | Blueberry lozenge for relieving asthenopia and preparation method thereof |
| CN103494134B (en) * | 2013-08-28 | 2015-06-24 | 沈阳农业大学 | Blueberry lozenge for relieving asthenopia and preparation method thereof |
| CN104621552A (en) * | 2013-11-12 | 2015-05-20 | 江苏艾兰得营养品有限公司 | Eyesight protecting and improving chewable tablet and preparation method thereof |
| CN105533316A (en) * | 2014-11-04 | 2016-05-04 | 威海特伦斯生物工程有限公司 | Production method of blueberry chewable tablets for alleviating visual fatigue |
| CN104366328A (en) * | 2014-11-07 | 2015-02-25 | 柳城县天地自然食品有限公司 | Chewable tablets containing blueberries and poria cocos, and preparation method of chewable tablets |
| CN104522645A (en) * | 2014-12-09 | 2015-04-22 | 大兴安岭至臻尚品寒带生物技术有限公司 | Formula of blueberry anthocyanin tablets and production process of blueberry anthocyanin tablets |
| CN104814995A (en) * | 2015-05-12 | 2015-08-05 | 沈小玲 | Oriental blueberry fruit powder health product composition as well as preparation method and application thereof |
| CN106036626A (en) * | 2016-06-16 | 2016-10-26 | 湖北工业大学 | Mulberry wine lees chewable tablet preparation method |
| CN106343548A (en) * | 2016-08-24 | 2017-01-25 | 东北林业大学 | Composite licoflavone blueberry juice chewable tablet and preparation method thereof |
| CN106343548B (en) * | 2016-08-24 | 2019-08-02 | 东北林业大学 | A kind of licoflavone composite blueberry juice chewable tablets and preparation method thereof |
| CN110710673A (en) * | 2019-09-26 | 2020-01-21 | 南宁海王健康生物科技有限公司 | Blueberry compound vitamin C chewable tablet and preparation method thereof |
| CN110522030A (en) * | 2019-10-12 | 2019-12-03 | 烟台华康海洋食品有限公司 | A kind of sea cucumber nutrient chewable tablets and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103070338B (en) | 2013-11-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103070338B (en) | Blueberry chewable tablet | |
| CN101103830B (en) | Pumpkin sweet-corn beverage and preparation method thereof | |
| CN104509899A (en) | Lotus root blueberry beverage | |
| CN103169020A (en) | Health-care rice for men and preparation method thereof | |
| CN102613290A (en) | Black corn sour milk and preparation method thereof | |
| CN104432036A (en) | Health care nutrition composition capable of relieving asthenopia as well as preparation method and application thereof | |
| CN107183290A (en) | A kind of lycium ruthenicum pressed candy and preparation method thereof | |
| CN101411381B (en) | Freezing beverage containing aloe juice and carrot juice and preparation method thereof | |
| CN101411422B (en) | Tomato and peach pieces | |
| CN102870885A (en) | Lotus root and fructus lycii milk tea and preparation technology thereof | |
| CN104286614A (en) | Formula of intestine-protecting and lead-excreting fruit cakes and processing method of intestine-protecting and lead-excreting fruit cakes | |
| CN102177967A (en) | Black milk and production method thereof | |
| CN101785505B (en) | Black soya bean soymilk beverage and production method thereof | |
| CN102048076A (en) | Pure-natural plant-synthesized yam beverage | |
| CN101449824A (en) | Blueberry rose-hip bee pollen food | |
| CN103988911A (en) | Black potato buffalo milk dairy product and preparation method thereof | |
| CN102919648A (en) | Nutrient and health-care highland barley jelly and preparation method thereof | |
| CN101461555B (en) | Plant protein beverage and method for preparing the same | |
| CN106722891A (en) | A kind of blueberry chewable tablet | |
| KR101834638B1 (en) | The method of functional korea traditional cracker using the jujube | |
| CN104116032A (en) | Nutritional breakfast with hair-blacking and beautifying efficacy and preparation method | |
| CN104413324A (en) | Jackfruit and banana jelly | |
| CN104232393A (en) | White grape wine containing spirulina | |
| CN102550929A (en) | Millet Chinese wolfberry powder | |
| CN107969586A (en) | A kind of lotus fermented beverage and production method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| ASS | Succession or assignment of patent right |
Owner name: LIAONING QIANLIMING PHARMACEUTICAL (GROUP) CO., LT Free format text: FORMER OWNER: LIN JIHUA Effective date: 20131016 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20131016 Address after: 110000 No. 76, unity Road, Shenhe District, Liaoning, Shenyang Applicant after: Liaoning Qianliming Pharmaceutical (Group) Co., Ltd. Address before: 110000 No. 76, unity Road, Shenhe District, Liaoning, Shenyang Applicant before: Lin Jihua |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant |